{"protocolSection": {"identificationModule": {"nctId": "NCT03031847", "orgStudyIdInfo": {"id": "PRO17010015"}, "organization": {"fullName": "University of Pittsburgh", "class": "OTHER"}, "briefTitle": "Cardiac Resynchronization in the Elderly", "officialTitle": "Cardiac Resynchronization in the Elderly: Piloting Pacemaker vs. Defibrillator Therapy (Randomized Trial)"}, "statusModule": {"statusVerifiedDate": "2023-12", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2017-03-21", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2021-08-18", "type": "ACTUAL"}, "completionDateStruct": {"date": "2021-08-18", "type": "ACTUAL"}, "studyFirstSubmitDate": "2017-01-19", "studyFirstSubmitQcDate": "2017-01-25", "studyFirstPostDateStruct": {"date": "2017-01-26", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2022-07-19", "resultsFirstSubmitQcDate": "2022-07-27", "resultsFirstPostDateStruct": {"date": "2022-08-23", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2023-12-04", "lastUpdatePostDateStruct": {"date": "2023-12-07", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR_INVESTIGATOR", "investigatorFullName": "Samir Saba", "investigatorTitle": "Associate Professor; Associate Chief of Cardiology; Director of Cardiovascular Electrophysiology", "investigatorAffiliation": "University of Pittsburgh"}, "leadSponsor": {"name": "Samir Saba", "class": "OTHER"}}, "oversightModule": {"oversightHasDmc": true, "isFdaRegulatedDrug": false, "isFdaRegulatedDevice": true}, "descriptionModule": {"briefSummary": "This pilot will enroll 50 HF patients (age \u2265 75 years) undergoing CRT device implantation at the hospitals of the University of Pittsburgh Medical Center, Duke University, Ohio State University, and the VA Pittsburgh Healthcare System. Patients will be randomized to CRT-P versus CRT-D and followed until study end. Rates of patient screening, enrollment, randomization, and retention as well as cost of care will be examined. The results of this pilot study will inform the design of a large pivotal non-inferiority trial and will be necessary for its success. Patients who refuse participation in the randomized pilot trial will be asked to enroll in a prospective observational cohort. Characteristics of patients who choose CRT-P vs. CRT-D will be compared and patients' level of satisfaction with their device decision will be measured.", "detailedDescription": "The goal of this study is to pilot test a randomized, controlled, non-inferiority trial comparing the survival and quality of life (QOL) of older patients receiving cardiac resynchronization therapy (CRT) pacemaker (CRT-P) versus defibrillator (CRT-D) therapy. This pilot will enroll 50 HF patients (age \u2265 75 years) undergoing CRT device implantation at the hospitals of the University of Pittsburgh Medical Center, Duke University, Ohio State University, and the VA Pittsburgh Healthcare System. Patients will be randomized to CRT-P versus CRT-D and followed until study end. Rates of patient screening, enrollment, randomization, and retention as well as cost of care will be examined. The results of this pilot study will inform the design of a large pivotal non-inferiority trial and will be necessary for its success. Patients who refuse participation in the randomized pilot trial will be enrolled and followed as part of a prospective observational cohort. Characteristics of patients who choose CRT-P vs. CRT-D will be compared and patients' level of satisfaction with their device decision will be measured."}, "conditionsModule": {"conditions": ["Heart Failure"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "interventionModelDescription": "Randomized, open-label, controlled trial of CRT-P vs. CRT-D in HF patients (age \u2265 75 years)", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 102, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Randomized- Pacemaker (CRT-P)", "type": "OTHER", "description": "Cardiac resynchronization therapy Pacemaker", "interventionNames": ["Device: Cardiac Resynchronization Therapy Pacemaker"]}, {"label": "Randomized- Defibrillator (CRT-D)", "type": "OTHER", "description": "Cardiac resynchronization therapy Defibrillator", "interventionNames": ["Device: Cardiac Resynchronization Therapy Defibrillator"]}, {"label": "Observational- Pacemaker (CRT-P)", "type": "OTHER", "description": "Cardiac resynchronization therapy Pacemaker (CRT-P): Patients in this arm declined randomization in the trial and elected to participate in the observational registry", "interventionNames": ["Device: Cardiac Resynchronization Therapy Pacemaker"]}, {"label": "Observational- Defibrillator (CRT-D)", "type": "OTHER", "description": "Cardiac resynchronization therapy Defibrillator (CRT-D): Patients in this arm declined randomization in the trial and elected to participate in the observational registry", "interventionNames": ["Device: Cardiac Resynchronization Therapy Defibrillator"]}], "interventions": [{"type": "DEVICE", "name": "Cardiac Resynchronization Therapy Pacemaker", "description": "Patients randomized to the pacemaker arm will receive a CRT-P device.", "armGroupLabels": ["Observational- Pacemaker (CRT-P)", "Randomized- Pacemaker (CRT-P)"], "otherNames": ["CRT-P"]}, {"type": "DEVICE", "name": "Cardiac Resynchronization Therapy Defibrillator", "description": "Patients randomized to the defibrillator arm will receive a CRT-D device.", "armGroupLabels": ["Observational- Defibrillator (CRT-D)", "Randomized- Defibrillator (CRT-D)"], "otherNames": ["CRT-D"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Enrollment", "description": "Rates of enrollment of participants in this randomized trial", "timeFrame": "At 1 year after start of the study"}], "secondaryOutcomes": [{"measure": "QOL", "description": "Quality of life of CRT-P versus CRT-D recipients using Minnesota Living with Heart Failure Questionnaires. The Minnesota Living with Heart Failure scale ranges from 0 to 105, in which a lower score indicates a better outcome. The Minnesota Living with Heart Failure Physical subscale ranges from 0 to 40 and the Minnesota Living with Heart Failure Mental subscale ranges from 0 to 25. Lower scores on the subscales indicate a better outcome.", "timeFrame": "At 6 months after enrollment"}, {"measure": "QOL2", "description": "QOL of CRT-P versus CRT-D recipients using RAND-36. The RAND-36 is a normalized scale with a range of 0 to 100, in which a higher score is indicative of a better outcome. PCS-T and MCS-T are the two summary components of the RAND-36. The subscales PCS-T and MCS-T are both normalized with a range of 0 to 100. Higher scores on the subscales indicate a better outcome.", "timeFrame": "At 6 months after enrollment"}, {"measure": "Retention", "description": "Rates of retention of participants in this randomized trial", "timeFrame": "At 6 months after enrollment"}, {"measure": "Health Care Cost", "description": "Cost of health care between CRT-P and CRT-D recipients.", "timeFrame": "At 6 months after enrollment"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n1. Age \\>/= 75 years\n2. Left Ventricular Ejection Fraction (LVEF) \u2264 35% by cardiac imaging including echocardiogram, nuclear imaging, cardiac catheterization, or cardiac magnetic resonance imaging\n3. QRS width \\>120 ms on surface electrocardiogram\n4. New York Heart Association class II, III, or ambulatory IV for Heart Failure (HF)\n5. Patient undergoing de novo CRT device implantation of CRT-D device change-out for battery depletion\n\nExclusion Criteria:\n\n1. Patient within 40 days of acute myocardial infarction\n2. Patient within 3 months of cardiac revascularization (percutaneous coronary intervention or bypass surgery)\n3. Patient with prior history of cardiac arrest or documented sustained ventricular arrhythmia\n4. Patient with expected longevity \\< 1 year\n5. Patient not on optimal medical therapy for HF management including when tolerated \u03b2-blockers, angiotensin converting enzyme inhibitors or angiotensin receptor blockers\n6. Patient not planning to have his/her follow-up at participating institution\n7. Patient unable or unwilling to sign a written informed consent\n8. Patient's with dementia that are unable to consent for themselves\n9. Participating in any other clinical trials (observational/registries allowed)", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "75 Years", "stdAges": ["OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Samir Saba, MD", "affiliation": "University of Pittsburgh", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Duke University Health System", "city": "Durham", "state": "North Carolina", "zip": "27710", "country": "United States", "geoPoint": {"lat": 35.99403, "lon": -78.89862}}, {"facility": "The Ohio State University", "city": "Columbus", "state": "Ohio", "zip": "43210", "country": "United States", "geoPoint": {"lat": 39.96118, "lon": -82.99879}}, {"facility": "UPMC Hamot", "city": "Erie", "state": "Pennsylvania", "zip": "16550", "country": "United States", "geoPoint": {"lat": 42.12922, "lon": -80.08506}}, {"facility": "UPMC", "city": "Pittsburgh", "state": "Pennsylvania", "zip": "15213", "country": "United States", "geoPoint": {"lat": 40.44062, "lon": -79.99589}}, {"facility": "Veterans Research Foundation of Pittsburgh", "city": "Pittsburgh", "state": "Pennsylvania", "zip": "15240", "country": "United States", "geoPoint": {"lat": 40.44062, "lon": -79.99589}}, {"facility": "UPMC Pinnacle", "city": "Wormleysburg", "state": "Pennsylvania", "zip": "17043", "country": "United States", "geoPoint": {"lat": 40.26287, "lon": -76.91386}}]}, "referencesModule": {"references": [{"pmid": "36350362", "type": "DERIVED", "citation": "Dhande M, Myaskovsky L, Althouse A, Singh M, Weiss R, Shalaby A, Al-Khatib SM, Topoll A, Jain S, Saba S. Quality of Life and Type of Cardiac Resynchronization Therapy Device in Older Heart Failure Patients. J Palliat Med. 2023 Apr;26(4):481-488. doi: 10.1089/jpm.2022.0217. Epub 2022 Nov 8."}, {"pmid": "35357219", "type": "DERIVED", "citation": "Althouse AD, Jain SK, Shalaby A, Singh M, Weiss R, Myaskovsky L, Al-Khatib SM, Saba S. Feasibility of a Randomized Clinical Trial of Cardiac Resynchronization Therapy With or Without an Implantable Defibrillator in Older Patients. Circ Arrhythm Electrophysiol. 2022 Apr;15(4):e010795. doi: 10.1161/CIRCEP.121.010795. Epub 2022 Mar 31. No abstract available."}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Randomized- Pacemaker (CRT-P)", "description": "Patients assigned to the pacemaker arm will receive CRT-P device"}, {"id": "FG001", "title": "Randomized- Defibrillator (CRT-D)", "description": "Patients assigned to the defibrillator arm will receive CRT-D device"}, {"id": "FG002", "title": "Observational- Pacemaker (CRT-P)", "description": "Patients in observational arm that chose CRT-P device"}, {"id": "FG003", "title": "Observational- Defibrillator (CRT-D)", "description": "Patients in observational arm that chose CRT-D device"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "22"}, {"groupId": "FG001", "numSubjects": "20"}, {"groupId": "FG002", "numSubjects": "18"}, {"groupId": "FG003", "numSubjects": "42"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "20"}, {"groupId": "FG001", "numSubjects": "18"}, {"groupId": "FG002", "numSubjects": "14"}, {"groupId": "FG003", "numSubjects": "36"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "6"}]}], "dropWithdraws": [{"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "2"}, {"groupId": "FG003", "numSubjects": "3"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "2"}, {"groupId": "FG003", "numSubjects": "3"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Randomized- Pacemaker (CRT-P)", "description": "Patients assigned to the pacemaker arm will receive CRT-P device"}, {"id": "BG001", "title": "Randomized- Defibrillator (CRT-D)", "description": "Patients assigned to the defibrillator arm will receive CRT-D device"}, {"id": "BG002", "title": "Observational- Pacemaker (CRT-P)", "description": "Patients in observational arm that chose CRT-P device"}, {"id": "BG003", "title": "Observational- Defibrillator (CRT-D)", "description": "Patients in observational arm that chose CRT-D device"}, {"id": "BG004", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "22"}, {"groupId": "BG001", "value": "20"}, {"groupId": "BG002", "value": "18"}, {"groupId": "BG003", "value": "42"}, {"groupId": "BG004", "value": "102"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "22"}, {"groupId": "BG001", "value": "20"}, {"groupId": "BG002", "value": "18"}, {"groupId": "BG003", "value": "42"}, {"groupId": "BG004", "value": "102"}]}]}]}, {"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "80.7", "spread": "4.3"}, {"groupId": "BG001", "value": "81.4", "spread": "4.9"}, {"groupId": "BG002", "value": "84.7", "spread": "4.6"}, {"groupId": "BG003", "value": "80.6", "spread": "4.0"}, {"groupId": "BG004", "value": "81.5", "spread": "4.5"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "7"}, {"groupId": "BG001", "value": "7"}, {"groupId": "BG002", "value": "6"}, {"groupId": "BG003", "value": "8"}, {"groupId": "BG004", "value": "28"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "15"}, {"groupId": "BG001", "value": "13"}, {"groupId": "BG002", "value": "12"}, {"groupId": "BG003", "value": "34"}, {"groupId": "BG004", "value": "74"}]}]}]}, {"title": "Ethnicity (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "1"}]}, {"title": "Not Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "21"}, {"groupId": "BG001", "value": "20"}, {"groupId": "BG002", "value": "18"}, {"groupId": "BG003", "value": "42"}, {"groupId": "BG004", "value": "101"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "3"}, {"groupId": "BG004", "value": "5"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "20"}, {"groupId": "BG001", "value": "18"}, {"groupId": "BG002", "value": "18"}, {"groupId": "BG003", "value": "38"}, {"groupId": "BG004", "value": "94"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "1"}, {"groupId": "BG004", "value": "3"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "22"}, {"groupId": "BG001", "value": "20"}, {"groupId": "BG002", "value": "18"}, {"groupId": "BG003", "value": "42"}, {"groupId": "BG004", "value": "102"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Enrollment", "description": "Rates of enrollment of participants in this randomized trial", "populationDescription": "Participants Enrolled", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "At 1 year after start of the study", "groups": [{"id": "OG000", "title": "Randomized- Pacemaker (CRT-P)", "description": "Patients assigned to the pacemaker arm will receive CRT-P device"}, {"id": "OG001", "title": "Randomized- Defibrillator (CRT-D)", "description": "Patients assigned to the defibrillator arm will receive CRT-D device"}, {"id": "OG002", "title": "Observational- Pacemaker (CRT-P)", "description": "Patients in observational arm that chose CRT-P device"}, {"id": "OG003", "title": "Observational- Defibrillator (CRT-D)", "description": "Patients in observational arm that chose CRT-D device"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "22"}, {"groupId": "OG001", "value": "20"}, {"groupId": "OG002", "value": "18"}, {"groupId": "OG003", "value": "42"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "22"}, {"groupId": "OG001", "value": "20"}, {"groupId": "OG002", "value": "18"}, {"groupId": "OG003", "value": "42"}]}]}]}, {"type": "SECONDARY", "title": "QOL", "description": "Quality of life of CRT-P versus CRT-D recipients using Minnesota Living with Heart Failure Questionnaires. The Minnesota Living with Heart Failure scale ranges from 0 to 105, in which a lower score indicates a better outcome. The Minnesota Living with Heart Failure Physical subscale ranges from 0 to 40 and the Minnesota Living with Heart Failure Mental subscale ranges from 0 to 25. Lower scores on the subscales indicate a better outcome.", "populationDescription": "Only participants with complete 6-month data for QoL assessments were reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "score on a scale", "timeFrame": "At 6 months after enrollment", "groups": [{"id": "OG000", "title": "Randomized- Pacemaker (CRT-P)", "description": "Patients assigned to the pacemaker arm will receive CRT-P device"}, {"id": "OG001", "title": "Randomized- Defibrillator (CRT-D)", "description": "Patients assigned to the defibrillator arm will receive CRT-D device"}, {"id": "OG002", "title": "Observational- Pacemaker (CRT-P)", "description": "Patients in observational arm that chose CRT-P device"}, {"id": "OG003", "title": "Observational- Defibrillator (CRT-D)", "description": "Patients in observational arm that chose CRT-D device"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "17"}, {"groupId": "OG001", "value": "17"}, {"groupId": "OG002", "value": "12"}, {"groupId": "OG003", "value": "32"}]}], "classes": [{"title": "Overall QOL: MLWHF Questionnaire", "categories": [{"measurements": [{"groupId": "OG000", "value": "31.5", "spread": "30.3"}, {"groupId": "OG001", "value": "16.1", "spread": "19.6"}, {"groupId": "OG002", "value": "18.4", "spread": "9.6"}, {"groupId": "OG003", "value": "37.8", "spread": "24.3"}]}]}, {"title": "Physical QOL", "categories": [{"measurements": [{"groupId": "OG000", "value": "14.1", "spread": "13.8"}, {"groupId": "OG001", "value": "8.2", "spread": "9.4"}, {"groupId": "OG002", "value": "10.7", "spread": "7.7"}, {"groupId": "OG003", "value": "18.9", "spread": "11.2"}]}]}, {"title": "Emotional QOL", "categories": [{"measurements": [{"groupId": "OG000", "value": "7.0", "spread": "7.9"}, {"groupId": "OG001", "value": "3.5", "spread": "5.4"}, {"groupId": "OG002", "value": "2.9", "spread": "2.8"}, {"groupId": "OG003", "value": "7.5", "spread": "7.0"}]}]}]}, {"type": "SECONDARY", "title": "QOL2", "description": "QOL of CRT-P versus CRT-D recipients using RAND-36. The RAND-36 is a normalized scale with a range of 0 to 100, in which a higher score is indicative of a better outcome. PCS-T and MCS-T are the two summary components of the RAND-36. The subscales PCS-T and MCS-T are both normalized with a range of 0 to 100. Higher scores on the subscales indicate a better outcome.", "populationDescription": "Only participants with complete 6-month data for QoL assessments were reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "score on a scale", "timeFrame": "At 6 months after enrollment", "groups": [{"id": "OG000", "title": "Randomized- Pacemaker (CRT-P)", "description": "Patients assigned to the pacemaker arm will receive CRT-P device"}, {"id": "OG001", "title": "Randomized- Defibrillator (CRT-D)", "description": "Patients assigned to the defibrillator arm will receive CRT-D device"}, {"id": "OG002", "title": "Observational- Pacemaker (CRT-P)", "description": "Patients in observational arm that chose CRT-P device"}, {"id": "OG003", "title": "Observational- Defibrillator (CRT-D)", "description": "Patients in observational arm that chose CRT-D device"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "17"}, {"groupId": "OG001", "value": "17"}, {"groupId": "OG002", "value": "12"}, {"groupId": "OG003", "value": "32"}]}], "classes": [{"title": "Rand-36: PCS-T", "categories": [{"measurements": [{"groupId": "OG000", "value": "37.4", "spread": "14.5"}, {"groupId": "OG001", "value": "45.0", "spread": "12.4"}, {"groupId": "OG002", "value": "37.7", "spread": "10.5"}, {"groupId": "OG003", "value": "35.0", "spread": "11.2"}]}]}, {"title": "Rand-36: MCS-T", "categories": [{"measurements": [{"groupId": "OG000", "value": "49.0", "spread": "13.4"}, {"groupId": "OG001", "value": "51.4", "spread": "10.4"}, {"groupId": "OG002", "value": "51.6", "spread": "10.4"}, {"groupId": "OG003", "value": "47.7", "spread": "13.7"}]}]}]}, {"type": "SECONDARY", "title": "Retention", "description": "Rates of retention of participants in this randomized trial", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "At 6 months after enrollment", "groups": [{"id": "OG000", "title": "Randomized- Pacemaker (CRT-P)", "description": "Patients assigned to the pacemaker arm will receive CRT-P device"}, {"id": "OG001", "title": "Randomized- Defibrillator (CRT-D)", "description": "Patients assigned to the defibrillator arm will receive CRT-D device"}, {"id": "OG002", "title": "Observational- Pacemaker (CRT-P)", "description": "Patients in observational arm that chose CRT-P device"}, {"id": "OG003", "title": "Observational- Defibrillator (CRT-D)", "description": "Patients in observational arm that chose CRT-D device"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "22"}, {"groupId": "OG001", "value": "20"}, {"groupId": "OG002", "value": "18"}, {"groupId": "OG003", "value": "42"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "17"}, {"groupId": "OG001", "value": "17"}, {"groupId": "OG002", "value": "12"}, {"groupId": "OG003", "value": "32"}]}]}]}, {"type": "SECONDARY", "title": "Health Care Cost", "description": "Cost of health care between CRT-P and CRT-D recipients.", "populationDescription": "Data was not collected", "reportingStatus": "POSTED", "timeFrame": "At 6 months after enrollment", "groups": [{"id": "OG000", "title": "Randomized- Pacemaker (CRT-P)", "description": "Patients assigned to the pacemaker arm will receive CRT-P device"}, {"id": "OG001", "title": "Randomized- Defibrillator (CRT-D)", "description": "Patients assigned to the defibrillator arm will receive CRT-D device"}, {"id": "OG002", "title": "Observational- Pacemaker (CRT-P)", "description": "Patients in observational arm that chose CRT-P device"}, {"id": "OG003", "title": "Observational- Defibrillator (CRT-D)", "description": "Patients in observational arm that chose CRT-D device"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "Up to 24 months.", "description": "Adverse events were collected and classified as serious or not serious, cardiac or not cardiac. Cardiac events were further differentiated by arrhythmic or non-arrhythmic. Adverse events were not classified by specific organ system.", "eventGroups": [{"id": "EG000", "title": "Randomized- Pacemaker (CRT-P)", "description": "Patients assigned to the pacemaker arm will receive CRT-P device.", "deathsNumAffected": 3, "deathsNumAtRisk": 22, "seriousNumAffected": 6, "seriousNumAtRisk": 22, "otherNumAffected": 9, "otherNumAtRisk": 22}, {"id": "EG001", "title": "Randomized- Defibrillator (CRT-D)", "description": "Patients assigned to the defibrillator arm will receive CRT-D device", "deathsNumAffected": 3, "deathsNumAtRisk": 20, "seriousNumAffected": 3, "seriousNumAtRisk": 20, "otherNumAffected": 6, "otherNumAtRisk": 20}, {"id": "EG002", "title": "Observational- Pacemaker (CRT-P)", "description": "Patients in observational arm that chose CRT-P device", "deathsNumAffected": 6, "deathsNumAtRisk": 18, "seriousNumAffected": 9, "seriousNumAtRisk": 18, "otherNumAffected": 2, "otherNumAtRisk": 18}, {"id": "EG003", "title": "Observational- Defibrillator (CRT-D)", "description": "Patients in observational arm that chose CRT-D device", "deathsNumAffected": 17, "deathsNumAtRisk": 42, "seriousNumAffected": 18, "seriousNumAtRisk": 42, "otherNumAffected": 13, "otherNumAtRisk": 42}], "seriousEvents": [{"term": "Cardiac", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 22}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 20}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 18}, {"groupId": "EG003", "numAffected": 14, "numAtRisk": 42}]}, {"term": "Non-Cardiac", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 22}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 20}, {"groupId": "EG002", "numAffected": 7, "numAtRisk": 18}, {"groupId": "EG003", "numAffected": 7, "numAtRisk": 42}]}], "otherEvents": [{"term": "Cardiac", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 22}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 20}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG003", "numAffected": 9, "numAtRisk": 42}]}, {"term": "Non-Cardiac", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 22}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 20}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 18}, {"groupId": "EG003", "numAffected": 5, "numAtRisk": 42}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Eric Pasquantonio", "organization": "UPMC Presbyterian Hospital", "email": "pasquantonioej@upmc.edu", "phone": "4126478210"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP", "hasProtocol": true, "hasSap": true, "hasIcf": false, "label": "Study Protocol and Statistical Analysis Plan", "date": "2018-05-24", "uploadDate": "2022-07-22T10:54", "filename": "Prot_SAP_000.pdf", "size": 711899}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}